Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R2KO
|
|||
| Former ID |
DIB000389
|
|||
| Drug Name |
CAF-01
|
|||
| Synonyms |
TDB; Liposomal adjuvant, Statens Serum Institut; Alpha,alpha'-trehalose 6,6'-dibehenate
Click to Show/Hide
|
|||
| Indication | Vaccination [ICD-11: N.A.] | Phase 1 | [1] | |
| Company |
Statens Serum Institut
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine. 2014 Dec 12;32(52):7098-107. | |||
| REF 2 | Mechanisms of Action of Adjuvants. Front Immunol. 2013; 4: 114. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.